Ezekiel Emanuel, Science Daily, Cancer Drug Shortages
LDI Senior Fellow and oncologist Ezekiel Emanuel is a co-author of a new study that found 83% of cancer doctors report that they've faced oncology drug shortages, and of those, nearly all say their patients' treatment has been impacted. The authors point to the necessity of creating new guidelines to deal with shortage-related issues. These include drug substitutions, priority populations for scarce drugs, and guidance on how to discuss treatment changes resulting from shortages with patients. Emanuel, PhD, MD, MSc, is Penn's Vice Provost for Global Initiatives, Chair of the Department of Medical Ethics and Health Policy.